# Use of Pyrvinium to Reverse Stomach Precancerous Conditions

> **NCT06782048** · PHASE2 · NOT_YET_RECRUITING · sponsor: **National University Hospital, Singapore** · enrollment: 50 (estimated)

## Conditions studied

- STOMACH NEOPLASM

## Interventions

- **DRUG:** Placebo
- **DRUG:** Pyrvinium
- **PROCEDURE:** Blood biomarkers analyses
- **PROCEDURE:** Oesophagogastroduodenoscopy (OGD) and biopsy
- **OTHER:** Gastric juice, saliva and stool collection and analyses

## Key facts

- **NCT ID:** NCT06782048
- **Lead sponsor:** National University Hospital, Singapore
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08
- **Primary completion:** 2029-12
- **Final completion:** 2029-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-01-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06782048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06782048, "Use of Pyrvinium to Reverse Stomach Precancerous Conditions". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06782048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*